CRISPR Therapeutics (NASDAQ:CRSP) Trading Down 0.2% on Analy

CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) shares dropped 0.2% during mid-day trading on Friday after Citigroup lowered their price target on the stock from $89.00 to $84.00. Citigroup currently has a buy rating on the stock. CRISPR Therapeutics traded as low as $55.21 and last traded at $55.61. Approximately 176,023 shares traded hands […]

Related Keywords

, Raju Prasad , Samarth Kulkarni , Barclays , Investment Management , Citigroup , Securities Exchange Commission , Wells Fargo Company , Cantor Fitzgerald , Vanguard Group Inc , Charles Schwab Investment Management Inc , Capital International Investors , Get Free Report , Wells Fargo , Exchange Commission , International Investors , Charles Schwab Investment Management , Schwab Investment Management , Stock Down ,